Clinical Trial Update: Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an allogeneic stem cell transplant regimen combining clofarabine, busulfan, and antithymocyte globulin in adults with high-risk AML, my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• Busulfex (busulfan)
• Clolar (Clofarabine)

Snippet

Sponsor: Nantes University Hospital | Conditions: MDS, AML | Phase 2 | Status: COMPLETED